Cuspart is a medical tracking app for diabetes management that uses a local-first, one-time payment model on iOS and Android.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Medical
Sentiment
5.0
1 reviews
Nemesis
Shotsy GLP-1 Tracker
The App DNA
What makes this app unique?
Users hire Cuspart to maintain clinical health records without the privacy risks or recurring costs associated with cloud-synced medical trackers.
For Individuals managing diabetes or glucose levels who require a private, offline-capable tool for health tracking and clinical reporting.
What does it look like?
Key features
Log glucose, insulin, and vitals without an active internet connection
Generate and share health history reports for physician review
Store all health data locally on the device rather than on external servers
How much does it cost?
Freemium model utilizing a one-time purchase to unlock offline capabilities, avoiding recurring subscription fatigue.
Velocity
Maintenance developmentUX improvementsperformanceopaqueShow more...
Development momentum has slowed significantly, with only 4 releases identified over the last 15 months. The latest release provided no descriptive notes, while previous updates focused on minor UI refinements and performance. There is no evidence of a live-ops strategy or a consistent feature-delivery pipeline. The current cadence of roughly 0.06 releases per week places the app firmly in the maintenance tier.
Who built it?
Mustafa Tolga DALBUDAK
13+ apps tracked · Medical
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Cuspart: Blood Sugar
How's the Medical market?
Cuspart maintains a niche position in the medical category by prioritizing local data storage over the cloud-sync features standard in the top 10 health trackers.
Read the market outlookThe rivals identified
By Shotsy
Shotsy directly competes for the same chronic condition management audience by focusing on medication adherence and glucose trends, mirroring Cuspart's goal of simplifying complex health data.
- Offers sophisticated medication level estimation which provides deeper clinical context than simple manual logging tools
- Maintains a high-velocity release cadence with five updates in six months, ensuring superior platform stability
- Leverages massive social proof and user volume to dominate search visibility within the health category
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Cuspart: Blood Sugar
Where is it heading?
The medical tracking market is consolidating around apps that offer automated wearable integration, leaving manual-entry tools like Cuspart increasingly exposed. The PM must transition from a manual-logging utility to an integrated health hub to prevent user migration to hardware-connected competitors.
- The recent Android launch expands the addressable market, allowing the app to capture users outside the iOS-only segment.
- The total lack of Android ratings post-launch suggests low discovery or high friction in the initial user funnel.
The SWOT
- Local-only data architecture eliminates cloud-based security risks
- One-time purchase model removes recurring subscription friction
- Develop Apple Health and Google Fit integration to reduce manual entry
- Target privacy-conscious users migrating from cloud-heavy competitors
Next best moves
Ship Apple Health and Google Fit integration because manual logging is the primary friction point → increase daily retention
+ 1 more prioritized moveThe counter-intuitive read
The privacy-first local storage is not just a…
Read the full takeFeature gaps
Automated CGM integration (available in GotCGM but missing here) +2
Since the last report: The competitive outlook shifted to address specific high-velocity rivals and the failure of the Android launch to generate user feedback.
Bottom line
Cuspart secures a privacy-focused niche through its local-first architecture, but the lack of automated CGM integration limits its long-term retention against hardware-connected rivals, so the PM must prioritize ecosystem data syncing to remain competitive.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated